About PEC Pharma

Our Heritage

Founded in India in 2015, the PEC Group has built an expert team in the healthcare field. PeriEleChem Pharma Pvt. Ltd. was promoted by the PEC Group, bringing extensive experience, expertise, and a proven track record in pharmaceutical materials supply and manufacture.

From our beginnings as a focused pharmaceutical materials supplier, PEC Pharma has grown into an integrated organisation serving more than 500 customers throughout India and expanding into international markets across LATAM, CIS, SEA and Africa. Our commitment to quality is reflected in every product category we offer.

What We Do

PEC Pharma is a leading supplier, manufacturer, and service provider of pharmaceutical materials. Our integrated portfolio covers the full pharmaceutical value chain:

• Complex APIs — commercial and development-stage active pharmaceutical ingredients
• Pharmaceutical Finished Formulations — tablets, capsules, suspensions and injectables
• Specialty Intermediates — high-purity building blocks for API synthesis
• CRDMO & CDMO — contract research, development and manufacturing
• Pharmaceutical Impurities — reference standards and analytical materials

Research & Compliance

We are a technology-based and market-driven company backed by a strong R&D setup. We aim at innovative production and thus creating a niche market for our products. We comply with all norms applicable as per high standard schedules.

Furthermore, PEC Pharma collaborates with various manufacturers complying with regulatory support for both domestic and international markets. Our investment in product development with DMF and dossier regulatory support helps partners achieve easier penetration in international markets.

Manufacturing Infrastructure

PEC Pharma operates from a corporate & R&D facility in Vadodara and a state-of-the-art commercial manufacturing plant in GIDC Saykha, District Bharuch, Gujarat. Our multipurpose plant is designed to meet strict regulatory standards while offering flexible multi-step synthetic capabilities:

• Plant Facilities & Footprint: Plant I consists of a G+2 floor building with 600 sq. m. (5,400 sq. ft.) available floor area. Plant II features 2,994.38 sq. m. of dedicated land reserved for future expansion.
• Installed Reaction Capacity: 16 KL Total Installed Capacity featuring high-capacity Glass-Lined Reactors (GMP GLR) and Stainless Steel Reactors (GMP SSR) ranging from 3 KL to 5 KL.
• GPCB Environmental Clearance: Granted process permissions under Environmental Clearance for 712 Pharmaceutical API & Intermediates Products, covering key reaction capabilities including Hydrogenation, Chlorination, Bromination, Sulphonation, Nitration, and Amination.
• Utility & Auxiliary Support: Equipped with a 1 MT Bio-Coal Fired Boiler, 200 TR Process Cooling Tower, 40 TR (-10°C) Brine Chiller, 500 KVA Transformer, 125 KVA DG Backup, Two-Stage HDPE Scrubber, and Venturi Vacuum systems.

Customer satisfaction is our primary objective, and our infrastructure is continuously upgraded to meet evolving global pharmaceutical industry standards and customer expectations.